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A critical regulatory laterality gene expressed in the left side of the straight heart tube during development is Pitx2, which
when mutated in humans underlies Rieger’s Syndrome. Previously reported results have indicated that, when using
gain-of-function and loss-of function approaches of the chick cPitx2c isoform, this results in randomization of heart looping.
To determine whether Pitx2c misexpression affects downstream morphogenesis by altering the expression of specific
proteins in the myocardium during looping, after experimental manipulations, we analyzed immunohistochemically for the
extracellular matrix molecule flectin that normally is expressed predominantly in the left lateral plate mesoderm (LPM) and
left side of the straight chick heart tube before and during looping. We show here that the left-side predominance of flectin
is due to a delay in the timing of expression in one heart field vs the other. Experimental results indicate that misexpression
of Pitx2c in the heart fields using antisense or retroviral delivery perturbs the normal temporal pattern of flectin expression
in the left LPM relative to the right: abnormally leftward looping hearts show predominate right-sided flectin expression in
the dorsal mesocardial regions around the foregut ventral midline. Additionally, Pitx2c misexpression affects the
positioning of the developing foregut to more lateral areas, either on the right or left side of the embryonic midline. The
position of the heart with respect to the embryo midline is defined by the position of the foregut. Incubating embryos in the
presence of flectin antibody caused randomization of heart looping or no looping. © 2002 Elsevier Science (USA)
Key Words: flectin; Pitx2; left–right asymmetry; embryonic midline; foregut floor; chick embryo; dorsal mesocardium;
heart looping.INTRODUCTION
For studies on embryonic left–right axis determination,
the rightward or dextral directionality of heart looping has
served as a key downstream morphologic readout of the
effects of manipulation of upstream genes associated with
laterality pathways in the early chick embryo. Perturbation
of upstream laterality genes, such as sonic hedgehog (Shh),
activin  and the activin receptor IIa, nodal, Lefty1, and
Lefty2, can result in randomization of the direction of heart
looping. The bicoid-like homeobox laterality gene Pitx2,
which is downstream of nodal in all vertebrates examined,
is of particular interest in this study because it is first
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All rights reserved.expressed in the left lateral plate mesoderm (LPM) and,
unlike the more upstream signaling cascade of factors, it
subsequently is expressed in the left side of the straight
heart tube (Logan et al., 1998; Meno et al., 1998; Piedra et
al., 1998; Ryan et al., 1998; St. Amand et al., 1998). This
organotypic expression and functional analyses indicate
that Pitx2 may serve to interface the left–right developmen-
tal program with morphogenesis to result in dextral looping
(Campione et al., 1999; Logan et al., 1998; Ryan et al.,
1998). Recently, it was shown that it is the Pitx2c isoform
that is expressed in the chick left heart field and left heart
tube and regulates rightward heart looping (Yu et al., 2001).
The downstream targets of Pitx2, however, are currently
unknown. Pitx2 encodes a transcription factor that prefer-
entially binds to the bicoid homeodomain binding site and
transactivates reporter genes containing this site (Amendt
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et al., 1998). The transactivation domain of Pitx2 has been
mapped to the C terminus (Yu et al., 2001).
The early morphoregulatory events of heart development
have been analyzed in the greatest detail in the chick. After
cardiac cell compartmentalization takes place between
stages 6 and 8 (Linask, 1992; Linask et al., 1997), the two
bilateral cardiac myocardial compartments bend ventrally
to form partial tube-like structures, which fuse in a cepha-
locaudad manner to form a single straight heart tube which
then begins to loop and beat. Directionality of looping is
easily discernible at the 11-somite stage. Looping appears to
be intrinsic to the heart (Nakamura and Manasek, 1978),
but does not require the presence of the cardiac jelly
(Baldwin and Solursh, 1989; Nakamura and Manasek,
1978), which is an extended highly organized extracellular
matrix (ECM) compartment sandwiched between the endo-
cardium and myocardium during the looping stages. Loop-
ing also does not appear to result from differential myocar-
dial cell proliferation (Stalsberg, 1969, 1970).
Before and during heart bending, the bilateral plate me-
soderm and subsequently the tubular heart show asymmet-
ric localization of several ECM proteins, such as flectin
(Tsuda et al., 1996, 1998), Lamp1, and JB3 (Smith et al.,
1997). In this study, we show that the myocardial, including
FIG. 1. Expression of flectin at approximately the four-somite stage in the heart fields. (A) Immunolocalization. (B) Computer-assisted
intensity profile of image in (A) with white designating highest intensity, blue lowest. In this ventral view of the embryo, flectin first is
synthesized chiefly in a localized region in the anterior left (L) heart-forming region. A small amount of flectin is detectable across the
midline and in the right (R) lateral plate mesoderm at this time. Several hours later at stage 9 (C), flectin on the left is now detectably
localizing further caudad than on the right. The horizontal lines demarcate the left–right posterior-most limits of its detection at this stage.
By stage 10 at the straight heart tube stage (D), flectin continues to localize in an asymmetric manner as can be seen in this confocal
optical section with flectin localization indicated by red signal and at a higher intensity, by yellow. Thus, the asymmetry arises from a delay




embryos R L M
RCAS-Pitx2 16 5 (3) 6 (4) 5 (3)
RCAS-GFP 11 9 (3) 2 (2) 0
Antisense oligo 14 8 (4) 5 (3) 1 (1)
Random oligo 5 4 (2) 1 (1)
Note. All embryos were immunostained and analyzed. Numbers
in parentheses indicate embryos sectioned. R, rightward looping; L,
leftward looping; M, midline not looping.
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FIG. 2. Expression patterns of cPitx2c mRNA by whole-mount in situ hybridization after retroviral or antisense manipulations of early
chick embryos. Whole-mount in situ hybridization was performed as described previously (St. Amand et al., 1998). In each panel, a ventral
view of stage 11 hearts is shown with the right (R) and left (L) axes indicated. Arrow points to the heart. (A) Expression in the left LPM and
left side of the heart tube in a control heart. (B) cPitx2x is now ectopically expressed in the right side of the heart tube as well, after
RCAS-Pitx2c infection in the right heart field at stage 3. This heart exhibited a reversed looping directionality. (C) Embryo shown had been
treated with antisense oligonucleotides specific to Pitx2c and showed a leftward looping heart with no Pitx2c expression within the heart
forming regions. However, expression of Pitx2c in the head mesoderm remains unaffected.
FIG. 3. Flectin localization in normal, right-looping hearts of control embryos. (A) Right heart fields were injected with RCAS-GFP. Hearts
loop normally. Left myocardial wall has rotated to form the outer curvature and shows more flectin expression than on the opposite side,
specifically in the myocardial region. Arrows point to the dorsal mesocardial areas. Note contrast in intensity of flectin in left (L) and right
(R) dorsal mesocardial folds. Asterisk pinpoints the midline of the floor of the foregut to which the endocardial cells attach via matrix
molecules. White diagonal line through the floor of neural tube and notochord area depicts embryo midline. Foregut midline is displaced
slightly right of embryonic midline. Magnification bar, 50 m. (B) Embryos were incubated in the presence of random sequence
oligonucleotides. In the majority of embryos, normal right looping occurred as seen in this embryo. More flectin is apparent in the left
myocardial wall that forms the outer curvature. Asymmetry of flectin expression is readily apparent in the dorsal mesocardial folds
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dorsal mesocardial, ECM asymmetry around the cardiac
midline, may be associated with the development of spe-
cific biophysical parameters within the heart tube to result
in dextral bending.
The downstream targets of laterality genes and why
randomization of the direction of heart looping occurs
when these genes are misexpressed have remained un-
known. The question of whether perturbation of upstream
genes within the laterality pathways affect matrix-related
morphoregulatory events of heart looping is addressed here
by ectopically expressing cPitx2c in the right LPM by
retroviral infection or by eliminating cPitx2c expression
from the left LPM using antisense oligonucleotides. The
effects of these manipulations on looping direction, flectin
expression, and midline structures were then assessed. In
addition, we show that if flectin interactions are blocked by
the F22 flectin antibody, looping direction becomes ran-
domized or hearts do not loop.
MATERIALS AND METHODS
Chick embryos. Fertilized White Leghorn chick eggs were used
for the experimental manipulations.
Retrovirus construction and infections. These were carried
out as previously described (Yu et al., 2001). Briefly, Pitx2c se-
quences were cloned into a ClaI2 adapter plasmid. The ClaI
fragments containing Pitx2c sequence were cloned into the RCAS
retroviral vector. Orientation was determined by PCR using an
upper primer targeting the retroviral sequence and a lower one
targeting the Pitx2 sequence. Generation and concentration of viral
supernatants were done according to Logan and Francis-West
(1999). RCAS retrovirus infection was performed by multiple
points of injection in the right side of the blastoderm of stage 3 or
stage 4 chick embryos (Hamburger and Hamilton, 1951) set up in
New culture (New, 1955). Control embryos similarly were injected
with RCAS vectors expressing green fluorescent protein (GFP).
Antisense oligonucleotide treatment was performed on stage 6–7
embryos set up in New culture as described earlier (Isaac et al.,
1997; Srivastava et al., 1995). The Pitx2c antisense oligonucleo-
tides has the sequence 5-GGTGTCAGAGATAGTGTG-3 tar-
geted to the N-terminal region. The random oligonucleotide,
5-AGGCTCGAACTCAGACTT-3, was used as the control. The
oligonucleotides were synthesized as phosphorothioate derivative
and HPLC purified (IDT, Corralville, IA). Oligonucleotides were
diluted to a concentration of 40 M in lipofectamine (Gibco/BRL).
Approximately 10 l of oligonucleotide/lipofectamine mixture was
applied directly onto the cultured embryo within the ring.
Table 1 shows the numbers of embryos treated and the direc-
tionality of heart looping at the end of the experiments. The
percentages of R/L looping hearts were similar to what had been
reported earlier (Yu et al., 2001). All embryos were immunostained
and analyzed in whole-mount. Embryos for sectioning indicated in
parentheses were picked at random within each treatment and
within the group showing either a right- or left-looping heart.
Flectin antibody perturbation experiments. Antibody pertur-
bation was performed by using stage 5 embryos set up on filter
paper rings as described earlier (Linask and Lash, 1988). This
method is a modification of the New culture technique. The flectin
F-22 monoclonal antibody was diluted 1:1 with normal 2:2:1
medium made up as described in the above citation, using an
F12X-based medium. Controls were set up in normal medium or in
mouse whole serum diluted similarly. Embryos were incubated
overnight for 24 h and heart looping directionality was scored. The
embryos were fixed in 4% paraformaldehyde/PBS, permeabilized,
and immunostained with antibody MF-20 (Developmental Studies
Hybridoma Bank, IA University) for sarcomeric myosin heavy
chain as a marker for the myocardium to analyze more precisely
heart morphology and the directionality of looping in whole
mounts.
In situ hybridization and immunostaining. All embryos were
allowed to develop to stage 11, and were then scored for direction-
ality of heart looping. Subsequently, randomly picked embryos
showing left- or right-looping hearts in each class of treatments
were fixed and immunostained, embedded in plastic, and serially
sectioned through the heart from anterior to posterior at 2-m
thickness, as previously described (Linask and Tsuda, 2000; Tsuda
et al., 1996). This provides high resolution, detailed analyses of
heart morphogenesis and protein localization. To determine effi-
ciency of retroviral infection and antisense elimination, treated
embryos and control embryos at stage 11 also were randomly
picked and whole-mount in situ hybridization was carried out by
using Pitx2c full-length probe, as described previously (St. Amand
et al., 1998).
Microscopy and photography. All sections were observed with
a Nikon Optiphot II fluorescence microscope. Digitized images
were captured directly with a Princeton Micromax cooled CCD
(mesocardial regions between arrow and arrowhead contrasted). The foregut midline, indicated by the asterisk, is displaced slightly left of
embryonic midline (denoted by white solid line). Arrow at outermost loop in (B) shows region where endocardium associates with the
myocardial wall. Magnification bar, 50 m. R, right side; L, left side; FG, foregut; NT, neural tube; EN, endocardial cells; MY, myocardium.
FIG. 4. Flectin expression in embryos injected into the right lateral plate mesoderm with RCAS-Pitx2c. (A) In a right-looping heart, more
flectin is present in the left myocardium (arrow). In addition, the ventral midline floor of the foregut (shown by arrowhead) is displaced to
the right of the embryo midline (indicated by the white solid line). This displacement, shown by broken white line, is more than that
observed in control embryos. (B) In a leftward looping heart, the displacement of the foregut is far to the left (L; compare position of broken
line relative to axis of embryo midline (solid line). Arrowhead depicts the midline of the foregut floor. The embryo midline is shown by solid
white line drawn through notochord. Definitive dorsal mesocardial folds are lacking and intensities of flectin localization signal appear to
be relatively equal on both sides of the myocardium with more extending up into the right myocardial wall (arrows) than on the left. In
embryos in which hearts looped to the left, the neural tissue often has remained as a flat sheet and has not folded to form a tube (see also
Fig. 5B). (C, D) Respective whole mounts of hearts that were sectioned and shown in (A) and (B). Broken line in (D) outlines edge of
notochord.
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camera interfaced with MetaMorph (Universal Imaging, West
Chester, PA) image processing analysis software.
RESULTS
A Timing Delay of Flectin Protein Expression in
Right Heart Field Results in Asymmetry
In order to understand the basis for the observed asym-
metry of flectin protein expression, we first determined
whether the timing of the appearance of the protein was the
same on both sides, with more protein being expressed over
time on the left relative to the right. Alternatively, the
protein could first be expressed on the left and, after a delay
on the right, also resulting in the observed asymmetry. To
resolve the correct scenario, we analyzed embryos for the
earliest expression of flectin protein by using immunohis-
tochemistry. The localization pattern indicates that the
flectin asymmetry is due to a timing delay in expression,
appearing first in a localized area in the left heart forming
region at approximately the 5- to 6-somite stage (Fig. 1A;
relative intensity levels shown in Fig. 1B, with white
indicating highest level of intensity). In this embryo, a low
level of expression is seen across the midline and sparse
localization is detectable in the right heart field. Once this
initial asymmetric pattern is established, it is maintained
throughout looping (Figs. 1C and 1D). Several hours of
development later (e.g., in a stage 9 embryo shown in Fig.
1C), flectin is expressed more caudad in the left side with
respect to the right (relative caudal limits of flectin expres-
sion demarcated by horizontal white lines). Figure 1D is a
confocal micrograph showing the typical left-dominant
expression pattern at the “straight heart tube” stage 10.
After looping, the total expression diminishes rapidly to a
low level within the myocardium (Tsuda et al., 1996). In
situ messenger RNA analysis by in situ hybridization of
stage 9 embryos provided similar results as in Fig. 1C in
that the left heart-forming region expressed message more
caudad than on the right (not shown).
Misexpression Experiments
To determine whether alterations of Pitx2c expression
which result in randomization of heart looping changes the
pattern of flectin expression, localization patterns of flectin
were analyzed in experimental embryos and compared with
controls. The predominant localization of flectin in the left
myocardium/dorsal mesocardium and little in the right
before and during looping suggested that flectin’s asymme-
try may be regulated indirectly by Pitx2, a left-sided-only
regulatory gene. Regulation can only be indirect, since
flectin is expressed in the right heart field, as well as left.
In experimental embryos, Pitx2c was misexpressed by
using either RCAS retroviral vectors in a gain-of-function
approach to ectopically express Pitx2c in the right LPM or
by using antisense oligonucleotides in a loss-of-function
manner in the left LPM. The experimental approaches to
misexpress Pitx2c were confirmed by whole-embryo in situ
hybridization for Pitx2c expression by random selection of
embryos from the experimental groups (Figs. 2A–2C). Con-
trol groups included use of RCAS-GFP constructs and
random oligonucleotides sequences. In control embryos,
the characteristic left-sided expression was seen (Fig. 2A). In
RCAS-Pitx2c gain-of-function, Pitx2c message was present
nearly equally on both sides of the heart (Fig. 2B). Loss-of-
function via antisense oligonucleotides resulted in no de-
tectable Pitx2c expression in the embryonic heart region.
Expression in the brain region remained unaffected. Ran-
domization of looping directionality in the experimental
embryos occurred as previously described (Yu et al., 2001).
Embryonic hearts were analyzed further for flectin expres-
sion along the anterior/posterior and left/right axes in stage
11 embryos, a time point at which looping directionality
can be clearly defined. We were especially interested in
flectin expression patterns in relation to the cardiac and
embryo midlines, as previous results have suggested that
the dorsal mesocardial region at the midline plays an
important role in looping (Taber et al., 1995; K.K.L., unpub-
lished observations).
The abnormally, leftward, looping hearts provided the
most information on looping in regards to the effects of
misexpressing Pitx2c. Pitx2c misexpression altered the sid-
edness of flectin expression, as well as sidedness of the
position of the foregut. The position of the developing heart
was seen to be related directly to the midline of the ventral
floor of the foregut, rather than the embryo midline. These
results are shown in Figs. 3A and 3B (hearts of control
embryos), Figs. 4A and 4B (gain-of-function study), Figs.
5A–5C, and Figs. 6A and 6B (loss-of-function study).
Control embryos. Control embryonic hearts in Fig. 3,
i.e., RCAS-GFP-injected embryo (Fig. 3A) and random
oligonucleotide-treated embryo (Fig. 3B), show the normal
left (L)-sided (i.e., outer curvature) predominance of flectin
expression around the cardiac midline. The initial left side
of the heart, as rotation occurs, becomes the convex outer
curvature on the ventral side. Note the contrast of flectin
expression levels in regions demarcated by small arrows
and arrowheads in the left and right mesocardial folds at the
foregut region. As described earlier, the endocardium ex-
tends from the ventral midline of the foregut (asterisk) to a
region at the outermost part of the loop (white arrow, Fig.
3B). Solid white diagonal lines drawn through the plane
connecting the ventral floor of the neural tube and noto-
chord regions denote the embryo midline. In the control
embryos, the ventral midline of the foregut (asterisk) is
positioned relatively close to the embryo midline, but not
exactly at the midline. In control embryos, the ventral floor
of the foregut is usually seen positioned slightly to the left
of the midline, but occasionally to the right (Fig. 3A). The
heart tube and endocardial attachments develop in relation
to the midline foregut floor. Directionality of looping is
associated with the predominance of flectin in the outer
curvature or initial left side of the heart and left dorsal
mesocardial fold.
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FIG. 5. Comparison of two antisense oligonucleotide-treated embryos showing opposite directionality of heart looping: a rightward
(normal direction, A) and leftward (abnormal direction, B). The asymmetry of flectin within the dorsal mesocardial folds (see arrows
pointing to side of higher level of expression) close to the cardiac midline is consistent with the direction of looping: More flectin in the
left (L) fold is consistent with the heart looping to the right; if more in the right (R) fold, the heart loop has looped to the left. White solid
line drawn through floor of neural tube and notochord depicts embryonic midline. Arrowhead shows the midline of the floor of the foregut;
broken line shows amount and direction of displacement of foregut from embryonic midline. In embryos with leftward looping hearts,
displacement of foregut is often much farther to the side than in right looping hearts. In (B), embryonic midline is at the upper left edge of
photograph (small arrow). Magnification bar in (B) for both panels, 25 m. N, neural tube; FG, foregut; EN, endocardium; MYO,
myocardium.
FIG. 6. Flectin expression in leftward looping heart of embryo treated with antisense oligonucleotides. The same heart is shown at
different levels as heart is sectioned serially from anterior to posterior. (A) Arrows point to the dorsal mesocardial area flanking the ventral
floor of the foregut (FG) in anterior region of heart. There is more flectin apparent in the right (R) mesocardial fold than in the left (L; see
arrows for regions to contrast). Otherwise, intensity of localization in the right and left side of the tubular heart wall is not very different.
(B) A more midlevel region of the same heart that is now beginning to show predominant localization of flectin in the left myocardial wall
which is seen at even higher intensity in (C) in a more caudad section. The asymmetry around the midline in (B) and (C) is not apparent,
as in (A). Thus, directionality appears to be determined by the anterior cardiac region, and is maintained during looping, regardless of
asymmetry posteriorly. Directionality apparently is not changed, once it is established and may be constrained by the extraembryonic
splanchnopleural membrane (sm) apposed close to the myocardium throughout looping. NT, neural tube; EN, endocardial cells; MY
myocardium, Magnification bar in (B), 25 m.
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Ectopic expression of Pitx2c in the right LPM. As
reported earlier, randomization of heart looping occurs
upon misexpression of Pitx2c (Yu et al., 2001). In embryos
in which the hearts continued to loop to the right (shown in
Fig. 4A, sectioned; Fig. 4C, whole mount), there continues
to be predominant expression of flectin in the left myocar-
dial wall. The dorsal mesocardial folds often are developed
and positioned abnormally, as are the endocardial exten-
sions and associations with the foregut and myocardial
wall. The heart has a more rounded appearance than that
seen in control embryos. Note that the ventral midline floor
of the foregut (arrowhead) is positioned in this embryo to
the right of the embryo midline (designated by the solid
white line cutting through plane of notochord and floor of
neural tube). In some embryos, the foregut may be posi-
tioned even more laterally than seen here or in control
embryos. Displacement of foregut is indicated by the bro-
ken arrow. Flectin localization around the notochord to the
extent apparent in this embryo is sometimes observed.
In embryos in which the hearts looped abnormally to the
left (shown in Fig. 4B, sectioned; Fig. 4D, whole mount),
noticeable differences are apparent: The hearts may show
nearly equal levels of flectin on the right and left sides often
with slightly more flectin on the right side, which becomes
the outer curvature in the abnormally left-looping hearts.
More flectin can be seen extending into the right dorsal
mesocardial fold than seen in left fold. In this embryo, the
mesocardial folds appear very abnormal. Here, the folds are
abnormally widely separated, and on the left side, it appears
to be associating with the lateral body fold rather than with
the foregut. The foregut midline (see arrowhead) in left-
looping hearts is displaced off to the far left side of the
embryo. The heart and endocardial attachments develop in
relation to the midline of the floor of the foregut. In the
leftward looping situation, neural tube closure was also
often abnormal. Whether misexpression of Pitx2c has a
general effect on bending or looping within the neural
region, body folds, as well as of the heart, cannot be ruled
out.
Antisense loss-of-Pitx2c expression in left LPM. Ran-
domization of heart looping is also observed in loss-of-
function studies. Similar to the results described above,
when Pitx2c expression is repressed or decreased within the
heart fields in the left lateral plate mesoderm, right-looping
hearts can develop (Fig. 5A). In these embryos, as in con-
trols, flectin is expressed at higher levels in the left (L)
dorsal mesocardial area (white arrow) and in the left myo-
cardial wall that becomes the outer curvature. Displace-
ment of foregut is to the right (R). In contrast, in leftward
looping hearts (Fig. 5B), flectin is predominant in the right
(R) mesocardial fold and right side of the heart extending
from the fold region. The right side of the heart due to
rotation becomes the outer curvature during leftward loop-
ing. The foregut has been displaced far to the left. In Fig. 5B,
the arrow in the upper left side of photograph indicates the
position of the notochord, which depicts the embryo mid-
line. The arrowhead indicates the midline of the floor of the
foregut. The broken line indicates the displacement of the
foregut to the embryonic left. The endocardial attachment
and cardiac midline are situated according to the midline of
the foregut.
Quantification of the displacement of the foregut and
statistical analysis of this displacement to the left or to the
right in the various treatments cannot be applied for pri-
marily two reasons: One can never be assured that the
developmental window is exactly the same at time of
exposure to the molecular treatments. Two embryos may
look the same, but heart development can be off by 3–4 h
between embryos. This can make a difference in the degree
of perturbation. In addition, there is no way to control that
efficiency of retroviral infection or antisense penetration is
always the same between embryos. Variability will be part
of these types of experiments. One can, however, determine
a pattern to the observed effects, as shown here. We are also
seeing similar affects by perturbing another gene associated
with the laterality pathway and that affects Pitx2 expres-
sion and flectin (unpublished observations).
That the asymmetry within the dorsal mesocardial folds
FIG. 7. Flectin antibody perturbation results in randomization of
heart looping or no looping. (A) An antibody-treated embryo with a
normal, right-looped heart, similar to control hearts. (B) A left-
looped heart after the experimental manipulation. (C) Some hearts
do not loop, while others show cardiabifida after treatment (D).
Thus, the flectin antibody perturbs the normal extracellular matrix
interactions to perturb fusion and/or heart looping. Magnification
bar, 50 m.
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in the anterior part of the heart appears to define the
directionality of heart looping is apparent from the cepha-
locaudad sequence of sections from the same heart that is
shown in Figs. 6A–6C. In this embryo treated with anti-
sense oligonucleotides in the left heart field, abnormal
leftward looping was observed. In anterior regions of the
heart, both sides of the myocardial wall showed similar
flectin expression levels and localization. However, within
the dorsal mesocardial area, more right (R)-sided asymme-
try is present in the two mesocardial folds (compare regions
indicated by arrows). More posteriorly, shown in Fig. 6B and
even further caudad in Fig. 6C, there is a detectable shift of
expression levels to the left side of the heart tube with
little, if any, flectin apparent in the dorsal mesocardium.
This shift in expression may be due to a slow degradation of
the perturbing antisense oligonucleotides, as differentiation
proceeds in an anterior–posterior wave across the heart-
forming regions. The left dominant expression seen caudad
would be more characteristic of rightward looping hearts
associated with normal and control embryos. The heart
tube, however, did not change the directionality of looping
posteriorly, but remained in a leftward loop position. Note
also that the extraembryonic splanchnic membrane (sm) is
always closely apposed to the myocardial wall, possibly
helping to constrain the heart to the direction that is
initially taken anteriorly.
Assessment of Antibody Perturbation of Flectin
Interactions
As has been reported, flectin F-22 antibody recognizes a
unique site on the protein that is highly conserved in all
11 species that have been analyzed (Mieziewska et al.,
1994, abstract). We used this antibody to assess whether
flectin may have a functional role in heart looping, as is
suggested by the misexpression experiments and by flec-
tin expression patterns before and during looping. Chick
embryos (n  30 in triplicate experiments) set up in ring
cultures (Linask and Lash, 1988) were exposed to the
antibody at stages 5–7 and were incubated overnight to
stages 11–12 next day at which time looping directional-
ity can be established. Based upon its localization pat-
tern, the heart region would be most accessible to the
antibody. After incubation, the embryos were fixed and
immunostained for cardiac myosin heavy chain using
MF20 antibody (Figs. 7A–7D. This allowed for more pre-
cise determination of cardiac morphology than only
bright field observation of whole-mount embryos. When
single tubular structures had formed, heart looping in
antibody-treated embryos became randomized, either
looping to the right (Fig. 7A; 35% of the embryos) or to
the left (Fig. 7B; 30%). In the leftward looping heart
shown here, the posterior region appeared somewhat bi-
furcated. Some tubular hearts did not loop and remained
straight, but had fused at the midline (Fig. 7C; 10%).
Some hearts (25%), which appeared under brightfield to
be single, wide hearts at the midline, were actually bifid
hearts and fusion had not taken place (Fig. 7D). These
bifid structures are not closed tubes, but in sections are
open, partial tube-like, structures. In control embryos,
90% (n  10) looped normally to the right. Therefore,
flectin appears functionally to have a role in direction of
heart looping and in fusion of the bilateral heart compart-
ments.
DISCUSSION
Flectin is an extracellular matrix molecule first char-
acterized in the interphotoreceptor matrix of the eye
(Mieziewska et al., 1994) and which may be involved in
the morphoregulation of a number of tissues and cell
types, including the neural crest. It is often, but not
exclusively, seen in embryonic tissues that undergo
bending. Characterization of the flectin cDNA sequence
and protein has been done by a different laboratory and
will be reported separately (Yoon et al.). The molecule
appears to be a member of a recently emerging class of
extracellular proteins, known as matricellular proteins,
all of which are functionally similar, but molecularly
distinct. The matricellular proteins mediate cell–matrix
interactions, can interact with other ECM molecules,
including growth factors, and are expressed chiefly in
tissues undergoing changes in cell–matrix and cell– cell
associations, such as occurs during tissue remodeling,
tissue renewal, and development (reviewed in Brekken,
2001). When flectin interactions were perturbed by ex-
posing stage 5 embryos to flectin F-22 monoclonal anti-
body, fusion of heart tubes were often abnormal or loop-
ing direction became randomized. Presently, the specific
biochemical interactions or cell signaling mediated by
flectin within the myocardium and dorsal mesocardial
folds are unknown. However, flectin participates in mor-
phoregulatory pathways involved in coordinating looping
and is modulated downstream by Pitx2c.
Vertebrates display bilateral asymmetry by the position-
ing of organs to the left or right of the body midline.
Individual organs display an intrinsic asymmetry during
their development, such as occurs in the brain, heart, and
lungs. How this intrinsic asymmetry is established is a
question that has attracted much interest, and great ad-
vances have been made towards characterizing upstream
molecular pathways that underlie early left–right pattern-
ing in the embryo (reviewed by Harvey, 1998). A prominent
downstream regulatory homeobox gene, Pitx2, has emerged
as an important player in chick and mouse heart laterality.
It is expressed in the left lateral plate mesoderm before the
tubular heart forms and later continues to be expressed in
the left side of the straight heart tube. An interesting
question from our perspective was: Are laterality genes
such as Pitx2c interfaced with organ morphogenesis by
modulating downstream morphoregulatory ECM mol-
ecules in the heart? The results of the present study suggest
that this is the case. Flectin expression and localization
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patterns are altered by Pitx2c misexpression. Flectin asym-
metry within the mesocardial folds at the cardiac midline
and within the myocardium in anterior regions of the
heart appears to have an important role in establishing
looping directionality. During randomization, mesocardial/
myocardial asymmetry showing left-sided predominance
will define the rightward movement of the heart, as is
seen in the normal embryo. Once defined, looping direc-
tion appears not to change, even if flectin expression and
localization is altered from its normal pattern more pos-
teriorly in the same heart. If the asymmetry is altered to
show right-sided predominance in more anterior regions,
the hearts then show leftward looping. Based on our
analyses, the left–right protein difference in expression
does not have to be large. Apparently, a small instability
on one side relative to the other is all that is needed for
looping directionality to be defined. That the dorsal me-
socardium has an important role in looping was sug-
gested earlier based on biomechanical and mathematical
concepts (Taber et al., 1995). Once directionality is es-
tablished, the extracellular membrane of splanchnic me-
soderm closely apposed to the myocardial wall may aid in
facilitating the bending of the heart tube in the direction
already prescribed.
Pitx2 appears to be able to modulate flectin expression
levels and localization patterns indirectly by affecting the
timing of flectin expression. Analysis of in ovo, untreated
embryos indicates that asymmetry is due to a timing
delay of protein synthesis on one side relative to the
other: Normally, flectin is first expressed on the left side
in a localized region, and later a wave of lower level of
expression progresses across the midline in some un-
known manner to the right, as shown diagrammatically,
to result in the observed asymmetric expression (Fig. 8A;
also see Figs. 1A and 1B). Thus, Pitx2 may activate an-
other intermediary molecule shown as “X,” or alterna-
tively, represses a repressor “X” that is present in both
fields or is only present at the midline, which then
activates/derepresses flectin expression on the contralat-
eral side. Because Pitx2 is in the left heart field, this
trigger occurs in the left field first and then is relayed to
the right. This type of left–right relay in signaling results
in a sufficient delay to produce the observed asymmetry
of flectin. If Pitx2 is misexpressed in the right field early,
then timing of flectin expression would occur earlier on
both sides to result in either nearly equal expression on
both sides of the heart wall/mesocardium, or more ex-
pression on right to the extent it allows looping direction
to be altered. When antisense treatment decreases Pitx2
expression on left, then this allows the endogenous right-
sided expression to become dominant and can result in
leftward looping. Since both antisense and retroviral ap-
proaches in chick embryos do not always result in com-
plete gain-of-function or loss-of-function of expression,
this suggests that Pitx2 function is dependent on specific
threshold concentrations being reached to properly ex-
ert its effect. Phenotypic characteristics of Rieger Syn-
drome in humans, where Pitx2 is mutated, are considered
to be due to haplo-insufficiency, which would also argue
for the importance of maintaining adequate levels of
Pitx2 .
Not only does Pitx2c misexpression alter directionality
of heart looping, but it also can alter positioning of the
foregut from its normal position slightly off the midline
to far more lateral left or right positions with respect to
the embryo midline. This occurs independently from the
positioning of the notochord underlying the neural tube,
which can be used as a marker for the embryo midline.
The heart, however, positions itself relative to the mid-
line of the ventral floor of the foregut. Possibly the left
expression of Pitx2c in the splanchnopleura of the heart
and gut fields not only determines leftness within the
heart and gut position, but also serves to define the
foregut midline boundary within a specific range of its
concentration. Any misexpression of these molecules, as
shown here with Pitx2c, that alters the normal balance of
concentrations on one side relative to the other can shift
the boundary to one side or the other of the embryo
midline. The foregut may align itself within a specific
concentration range of laterality specifying molecules.
The myocardium and endocardium, responding to spe-
cific signals emanating from the midregion of the ventral
floor of the foregut, become aligned relative to that re-
gion. Although a morphological effect on the midline and
positioning of the foregut is apparent, whether a midline
molecule is affected by altering normal Pitx2 concentra-
tions remains unknown. Midline signaling by the ventral
floor of the foregut, as it forms in an anterior/posterior
direction, is superimposed upon left/right fields to regu-
late subsequent steps (see also Bisgrove et al., 2000).
Candidate midline molecules shown to affect looping are
GATA-4 (Ghatpande et al., 2000; Molkentin et al., 1997)
and CFC (Schlange et al., 2001).
Heart looping is a complex, multifactorial process. Our
analysis of this process has made use of an extracellular
matrix protein flectin as a marker to follow downstream
events related to heart looping in the chick embryo.
Differential regulation of the timing of molecular expres-
sion in a left–right (L-R) manner in the heart fields, as
shown here for flectin, achieves bilateral asymmetry
within a few hours and provides a means of coordinating
complex processes with possibly fewer numbers of mol-
ecules than otherwise would be necessary. In the heart
fields, the timing of cell differentiation in an anterior–
posterior wave is superimposed upon the timing of ex-
pression of ECM and cellular components in a L-R man-
ner to achieve at times subtle, but definite, left–right
differences of protein expression (see also, in mouse,
Tsuda et al., 1998). Concomitantly, the timing of meso-
cardial attachment and detachment areas occurs in a
dorsal–ventral (D-V) manner. Heart development, from
its early induction by the anterior mesoderm, is tied
closely with development of the foregut throughout loop-
ing. Thus, key morphoregulatory molecules are being
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regulated on all three axes, along with the fourth dimen-
sion of timing to fine tune looping.
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